Strengthening Capital Through Stock Acquisition Rights with Exercise-Price Adjustment Clauses
First written in FY2018-Q3. 34 of 40 entries say "Advanced", first in FY2018. Latest entry: 2026-10-09.
0 other companies' latest entry also says "Softened".
- FY2026-H1AdvancedAnnual report
「During the current interim accounting period, the share acquisition rights attached to bonds with share acquisition rights subject to revision of the exercise price were exercised as follows. (12th Series of Share Acquisition Rights) Number of such share acquisition rights exercised during the current interim accounting period (rights) 22,260 Number of shares delivered upon exercise during the current interim accounting period (shares) 2,226,000 Amount raised through exercises during the current interim accounting period (¥ thousand) 569,340」
Of the 12th Series of Stock Acquisition Rights, 22,260 rights were exercised, 2,226,000 shares were issued, and ¥569.340 million was raised. Including the ¥90 million raised through a share issue, capital strengthening is making concrete progress. - FY2025AdvancedAnnual report
「At a meeting of the Board of Directors held on 21 November 2025, the Company resolved to issue new shares and stock acquisition rights through a private placement, with 8 December 2025 as the allotment date. It plans to raise funds through the issuance of new shares and through the exercise of stock acquisition rights.」
The company resolved to raise funds through a third-party allotment including the 12th and 13th Series Stock Acquisition Rights. After the filing, the issuance of 300,000 new shares and the exercise of stock acquisition rights equivalent to 610,000 shares under the 12th Series have progressed, giving concrete form to the strengthening of capital. - FY2025-H1AdvancedAnnual report
「The issuance of shares through the exercise of share acquisition rights increased share capital and capital surplus by ¥50 million each.」
During the current interim consolidated accounting period, 286,200 shares were issued through the exercise of share acquisition rights. Capital stock and capital surplus each increased by ¥50.262 million, and ¥100.170 million in funds was raised. - FY2024AdvancedAnnual report
「During the consolidated fiscal year, proceeds from the third-party allotment amounted to ¥200 million, while proceeds from the exercise of stock acquisition rights amounted to ¥214 million.」
The Company raised ¥200 million through a third-party allotment of shares and ¥214 million through the exercise of stock acquisition rights, making progress in strengthening its capital base. The 10th Series of Stock Acquisition Rights was issued for 2,286,000 underlying shares, with an exercise period from 10 September 2024 to 9 September 2026. - FY2024-Q2AdvancedAnnual report
「During the first six months of the fiscal year, the issuance of shares through the exercise of share acquisition rights increased capital stock by ¥107.606 million and capital surplus by ¥107.606 million.」
The exercise of stock acquisition rights increased capital and capital surplus by ¥107.606 million each during the six months ended September 30. Financing activities also included ¥214 million in proceeds from the exercise of stock acquisition rights, indicating progress in strengthening the capital base. - FY2024-Q1AdvancedAnnual report
「During the cumulative first-quarter consolidated period under review, the exercise of stock acquisition rights increased stated capital and capital surplus by ¥67.465 million each.」
Through the exercise of share acquisition rights, capital stock and capital surplus each increased by ¥67.465 million during the cumulative period of the first quarter, advancing the raising of capital. - FY2023AdvancedAnnual report
「Cash provided by financing activities was ¥33 million, compared with a ¥20 million decrease in the previous consolidated fiscal year. This was mainly because proceeds of ¥247 million from the issuance of shares upon the exercise of stock acquisition rights exceeded repayments of long-term borrowings of ¥190 million.」
The company repaid ¥190 million in long-term borrowings while recording ¥247 million in proceeds from the issuance of shares upon the exercise of stock acquisition rights, indicating progress in raising capital. - FY2023-Q3AdvancedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, the exercise of stock acquisition rights increased capital stock and capital surplus by ¥119.560 million each. In addition, a simplified share delivery increased capital stock and capital surplus by ¥82.987 million each.」
The exercise of stock acquisition rights increased stated capital and capital surplus by ¥119.560 million each, while a simplified share delivery increased each by ¥82.987 million, indicating progress in strengthening capital. - FY2023-Q2AdvancedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, cash provided by financing activities was ¥9 million, compared with ¥46 million used in the same quarter of the previous year. This was mainly due to ¥121 million in proceeds from the issuance of shares upon the exercise of stock acquisition rights and ¥92 million in repayments of long-term borrowings.」
Under its policy of raising funds through the 5th and 6th Series of Stock Acquisition Rights and other instruments, the Company recorded ¥121 million in proceeds from the issuance of shares upon exercise of stock acquisition rights, indicating progress in strengthening its capital base. - FY2023-Q1AdvancedAnnual report
「During the cumulative first quarter, the exercise of share acquisition rights increased stated capital and capital surplus by ¥15,076 thousand each.」
The exercise of stock acquisition rights progressed during the cumulative first-quarter period, increasing both stated capital and capital surplus by ¥15.076 million. - FY2022AdvancedAnnual report
「As of the end of the consolidated fiscal year, borrowings totaled ¥559 million, while proceeds from the issuance of shares and the issuance and exercise of stock acquisition rights during the fiscal year totaled ¥244 million.」
The company raised ¥244 million in equity-related funding during the fiscal year through a third-party allotment of new shares, the issuance of the fifth and sixth share acquisition rights, and the exercise of the fourth and sixth share acquisition rights and other rights. - FY2022-Q3AdvancedAnnual report
「At a meeting of the Board of Directors held on 22 September 2022, the company resolved to issue new shares and Fifth Series Stock Acquisition Rights through a third-party allotment to カントリーガーデン・ジャパン株式会社, as well as Sixth Series Stock Acquisition Rights through a third-party allotment to 創展環球有限公司. Payment in full for the total issue price of the new shares and the total issue price of the stock acquisition rights was completed on 12 October 2022.」
The Company issued 228,900 new shares through a third-party allotment and issued the fifth and sixth series of stock acquisition rights, with payment completed. The total amount to be raised, including proceeds from the exercise of the stock acquisition rights, is ¥687 million, which is planned to be allocated to working capital, acquisitions and equity investments, and repayment of borrowings. - FY2022-Q2AdvancedAnnual report
「During the cumulative second-quarter consolidated period, the exercise of stock acquisition rights increased capital stock by ¥33.116 million and capital surplus by ¥33.116 million.」
The exercise of stock acquisition rights progressed during the six months of the current second quarter consolidated fiscal period, increasing both share capital and capital surplus by ¥33.116 million. - FY2022-Q1AdvancedAnnual report
「During the cumulative first-quarter period, the exercise of stock acquisition rights increased capital stock by ¥33.116 million and capital surplus by ¥33.116 million.」
In the first quarter, capital stock and capital surplus each increased by ¥33.116 million through the exercise of stock acquisition rights, indicating progress in strengthening the capital base. - FY2021AdvancedAnnual report
「Cash provided by financing activities increased by ¥152 million, compared with an increase of ¥471 million in the previous consolidated fiscal year. This was mainly because, while repayments of short-term and long-term borrowings amounted to ¥164 million, the Company received ¥91 million from long-term borrowings and ¥223 million from the issuance of shares upon the exercise of stock acquisition rights.」
Funding raised through the exercise of the fourth share acquisition rights totaled ¥223 million cumulatively for the fiscal year, indicating progress in strengthening the capital base. - FY2021-Q3AdvancedAnnual report
「The Company completed financing through the issuance of new shares and raised ¥223 million during the cumulative third quarter of the current consolidated fiscal year through the exercise of the fourth series of stock acquisition rights.」
The Company completed financing through the issuance of new shares, bringing cumulative financing through the exercise of the 4th Stock Acquisition Rights through the third quarter to ¥223 million. Capital strengthening has progressed from the ¥196 million previously reported. - FY2021-Q2AdvancedAnnual report
「In addition to completing the financing through the issuance of new shares, the Company raised ¥196 million during the cumulative second-quarter period through the exercise of the fourth series of stock acquisition rights.」
The company completed the fund-raising through the issuance of new shares and raised ¥196 million during the nine-month period through the exercise of the 4th Series Stock Acquisition Rights. - FY2021-Q1AdvancedAnnual report
「Funding through the issuance of new shares has been completed, and the Company raised ¥163 million during the first quarter of the fiscal year under review through the exercise of the fourth series of stock acquisition rights.」
The company completed funding through the issuance of new shares and raised ¥163 million during the first quarter through the exercise of the fourth series of stock acquisition rights. - FY2020AdvancedAnnual report
「Cash provided by financing activities amounted to ¥471 million (a decrease of ¥19 million in the previous consolidated fiscal year). This was mainly due to proceeds of ¥100 million from long-term borrowings and proceeds of ¥406 million from the issuance of new shares through a third-party allotment and the exercise of share acquisition rights, which more than offset ¥32 million in repayments of short-term and long-term borrowings.」
The company raised a total of ¥406 million, including ¥149.994 million through a third-party allotment of new shares and ¥256.716 million through the exercise of the third series of stock acquisition rights. The third series of stock acquisition rights was fully exercised on 21 July 2020, and the company has newly issued a fourth series. - FY2020-Q3AdvancedAnnual report
「At a meeting of the Board of Directors held on 30 August 2019, the Company resolved to issue the 3rd Series of Stock Acquisition Rights with an Exercise Price Adjustment Clause by way of a third-party allotment, with 17 September 2019 as the allotment date, and the exercise of these stock acquisition rights was completed on 21 July 2020. In addition, at a meeting of the Board of Directors held on 31 August 2020, the Company resolved to issue new shares and the 4th Series of Stock Acquisition Rights by way of a third-party allotment, with 16 September 2020 as the allotment date. Number of convertible bonds with stock acquisition rights and other instruments exercised during the quarter 2,174 Number of shares delivered upon exercise during the quarter 217,400 Funds raised through exercises during the quarter (¥ thousand) 95,926」
The third series of stock acquisition rights was fully exercised on 21 July 2020. During the third quarter, 2,174 rights were exercised, raising ¥95.926 million through the issuance of 217,400 shares; cumulative figures were 7,366 rights, 736,600 shares and ¥319.174 million. The company also resolved to issue 320,500 new shares allocated on 16 September and 5,327 fourth-series stock acquisition rights, setting financing limits of ¥149.994 million for the new shares and ¥300.016 million for the fourth-series stock acquisition rights. - FY2020-Q2AdvancedAnnual report
「During the current second-quarter accounting period, the share acquisition rights attached to bonds with share acquisition rights subject to adjustment clauses for the exercise price were exercised as follows.」
In the second quarter, 2,297 stock acquisition rights were exercised, resulting in the issuance of 229,700 shares and the raising of ¥73.724 million. Cumulatively, the figures were 5,192 rights, 519,200 shares and ¥223.247 million, indicating progress in strengthening capital. - FY2020-Q1AdvancedAnnual report
「Number of such bonds with stock acquisition rights subject to exercise price adjustment clauses exercised during the quarter (units): 1,839” “Number of shares delivered upon exercise during the quarter (shares): 183,900” “Funds raised through exercise during the quarter (¥ thousands): 89,053」
During the first quarter, 1,839 stock acquisition rights were exercised, resulting in the delivery of 183,900 shares and fund-raising of ¥89.053 million. On a cumulative basis, these figures were 289,500 shares and ¥149.523 million, respectively. - FY2019ReframedAnnual report
「The 1st Series of Stock Acquisition Rights were acquired in full, comprising 1,166 units, on 30 August 2019 pursuant to a resolution of the Board of Directors held on that date, and all were cancelled on the same day.」
While the company acquired and cancelled the existing First and Second Series Stock Acquisition Rights, 1,056 Third Series Stock Acquisition Rights were exercised, raising ¥105.6 million through the issuance of 105,600 shares. The means of financing has therefore changed from the existing stock acquisition rights to the Third Series Stock Acquisition Rights. - FY2019-Q3AdvancedAnnual report
「At a board of directors meeting held on 30 August 2019, the company resolved to issue the third share acquisition rights of アサヒ衛陶株式会社 through a third-party allotment. Payment was completed and the rights were issued on 17 September 2019.」
The Company implemented a framework under which it issued 7,366 Series 3 share acquisition rights, representing 736,600 potential shares, and raised ¥444,280,290 from the issue proceeds and exercise proceeds combined. The proceeds are intended for structural reform, working capital for the overseas business, and the development of new products for the overseas business. During the current third-quarter accounting period, 50 rights were exercised, bringing cumulative shares delivered to 216,400 and cumulative funds raised to ¥202.109 million. - FY2019-Q2AdvancedAnnual report
「Number of bonds with stock acquisition rights with an exercise price adjustment clause exercised during the quarter (units): 547; number of shares delivered upon exercise during the quarter (shares): 54,700; funds raised through exercises during the quarter (¥ thousands): 40,671」
During the second-quarter accounting period, 547 stock acquisition rights were exercised, resulting in the issuance of 54,700 shares and ¥40.671 million in financing. On a cumulative basis, the figures were 211,400 shares and ¥198.511 million, respectively. - FY2019-Q1AdvancedAnnual report
「Number of such bonds with stock acquisition rights with an exercise price adjustment clause, etc., exercised during the quarter (units): 680; number of shares delivered upon exercise during the quarter (shares): 68,000; funds raised through exercises during the quarter (¥ thousand): 51,872」
In the first quarter, 680 stock acquisition rights were exercised, resulting in the delivery of 68,000 shares and ¥51.872 million in financing. Cumulatively, the figures were 156,700 shares and ¥157.840 million. - FY2018AdvancedAnnual report
「Cash provided by financing activities was ¥214 million, compared with a ¥61 million decrease in the previous consolidated fiscal year. This was mainly because proceeds of ¥400 million from long-term borrowings and ¥105 million from the issuance of shares upon the exercise of stock acquisition rights were partly offset by cash outflows of ¥288 million for the repayment of long-term borrowings.」
Of the stock acquisition rights issued, 887 were exercised, resulting in the delivery of 88,700 shares and the raising of ¥105.967 million. - FY2018-Q3First statedAnnual report
「On 27 August 2018, the company issued stock acquisition rights with provisions for adjustment of the exercise price. It intends to strengthen its capital base through the exercise of these stock acquisition rights.」
For the first time, the Company explicitly stated a measure to strengthen capital by issuing stock acquisition rights dated 27 August 2018. The first tranche covers 333,000 shares, with an exercise period from 27 August 2018 to 27 August 2020 and a minimum exercise price of ¥700.